Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07222826 · ClinicalTrials.gov registry record · NA

Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein

A NA study of Intracranial Pressure and Intracranial Pressure Changes, sponsored by Compremium.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07222826: Recruiting NA study of Intracranial Pressure and Intracranial Pressure Changes, sponsored by Compremium.

NCT07222826 is a NA study of Intracranial Pressure and Intracranial Pressure Changes that is actively recruiting participants, run by Compremium. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07222826, a NA study of Intracranial Pressure and Intracranial Pressure Changes, is actively recruiting participants, sponsored by Compremium.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Elevated intracranial pressure is a common complication of brain injury which means that the pressure within the skull rises above normal levels. The negative impact of increased intracranial pressure (ICP) on the prognosis of patients has been strongly shown in numerous studies and ICP-based treatment is associated with an important reduction of risk of death. Invasive ICP measurement methods are nowadays a standard of care in severe brain injury. The two available ways of measuring ICP require neurosurgical procedure to implant a catheter and probes within the brain and present risks and complications for the patient, such as infections and intracranial bleeding. In addition, invasive recording of ICP requires neurosurgical expertise and intensive care unit (ICU) facilities, limiting the application of ICP measurements to patients of the acute neuro-ICU (neuro-Intensive Care Unit) with acute brain damage requiring close surveillance to prevent further deterioration of neural tissue and disability. Non-invasive ICP monitoring benefits include no risk of complications seen in invasive monitoring, helping in deciding which patient needs invasive ICP monitoring, and providing ongoing long-term measurements of ICP without having to insert a new device every time. Although many non-invasive ICP measurement methods have been explored, to date, none of them have shown clinical success or usefulness. One under-explored window to ICP is the orbital vein, a small blood vessel located near your eye, which we think could provide a direct link to the intracranial pressure. The study device, called the CPMX3 system, is a non-invasive method to measure pressure in a superficial periorbital vein.

Interventions

  • DEVICE CPMX3

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-09-30
Est. Completion 2026-09-30
Phase NA
Compremium

2 total trials

What NCT07222826 shows while recruiting

NCT07222826 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Intracranial Pressure appearing as the primary indexed condition, and to 1 intervention - of which CPMX3 is the first listed.

NCT07222826 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07222826 about?

NCT07222826 is a clinical study titled "Non-invasive Intracranial Pressure Estimation by Measurement of the Occlusion Pressure of the Isolated Periorbital Vein". Elevated intracranial pressure is a common complication of brain injury which means that the pressure within the skull rises above normal levels. The negative impact of increased intracranial pressure (ICP) on the prognosis of patients has been strongly shown in numerous studies and ICP-based treatm...

What is the current status of trial NCT07222826?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-09-30. Estimated completion is 2026-09-30.

What conditions does trial NCT07222826 study?

This clinical trial studies the following conditions: Intracranial Pressure, Intracranial Pressure Changes.

What interventions are being tested in trial NCT07222826?

The interventions under investigation include: CPMX3 (DEVICE).

Who is sponsoring clinical trial NCT07222826?

This trial is sponsored by Compremium, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07222826 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracranial Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07222826's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07222826, the US trial registry maintained by the National Library of Medicine. NCT07222826 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.